Search
Patexia Research
Case number 1:17-cv-00665

OSI Pharmaceuticals, LLC et al v. Hetero USA Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Sep 7, 2017 18 SO ORDERED (2)
Docket Text: SO ORDERED - re [17] Stipulation of Dismissal (Consent Order of Dismissal) filed by Genentech, Inc., OSI Pharmaceuticals, LLC. Signed by Judge Gregory M. Sleet on 9/7/2017. ***Civil Case Terminated*** (mdb)
Sep 7, 2017 19 Patent/Trademark Report to Commissioner (3)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb)
Sep 6, 2017 17 Stipulation of Dismissal (2)
Docket Text: STIPULATION of Dismissal (Consent Order of Dismissal) by Genentech, Inc., OSI Pharmaceuticals, LLC. (Fahnestock, Derek) Modified on 9/6/2017 (mdb).
Sep 5, 2017 16 Stipulation to EXTEND Time (1)
Docket Text: Joint STIPULATION TO EXTEND TIME for Defendants to move, answer or otherwise respond to Plaintiffs' Complaint to September 12, 2017 - filed by Genentech, Inc., OSI Pharmaceuticals, LLC. (Fahnestock, Derek)
Aug 22, 2017 N/A SO ORDERED (0)
Aug 21, 2017 15 Stipulation (2)
Docket Text: STIPULATION and [Proposed] Order to Extend Time for Defendants to move, answer or otherwise respond to Plaintiffs' Complaint by Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc.. (Dorey, David)
Aug 7, 2017 N/A SO ORDERED (0)
Aug 7, 2017 13 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by David A. Dorey on behalf of Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc. (Dorey, David)
Aug 7, 2017 14 Stipulation to EXTEND Time (1)
Docket Text: Joint STIPULATION TO EXTEND TIME for Defendants to move, answer or otherwise respond to Plaintiffs' Complaint to August 21, 2017 - filed by Genentech, Inc., OSI Pharmaceuticals, LLC. (Fahnestock, Derek)
Jun 8, 2017 7 Request for Waiver of Service (1)
Docket Text: REQUEST FOR WAIVER of Service sent to Hetero USA Inc. on June 7, 2017 by Genentech, Inc., OSI Pharmaceuticals, LLC. Waiver of Service due by 7/7/2017. (Fahnestock, Derek)
Jun 8, 2017 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by OSI Pharmaceuticals, LLC, Genentech, Inc.: For Hetero USA Inc. waiver sent on 6/7/2017, answer due 8/7/2017. (Fahnestock, Derek)
Jun 8, 2017 9 Request for Waiver of Service (1)
Docket Text: REQUEST FOR WAIVER of Service sent to Hetero Labs Ltd. on 6/7/2017 by Genentech, Inc., OSI Pharmaceuticals, LLC. Waiver of Service due by 7/7/2017. (Fahnestock, Derek)
Jun 8, 2017 10 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by OSI Pharmaceuticals, LLC, Genentech, Inc.: For Hetero Labs Ltd. waiver sent on 6/7/2017, answer due 8/7/2017. (Fahnestock, Derek)
Jun 8, 2017 11 Request for Waiver of Service (1)
Docket Text: REQUEST FOR WAIVER of Service sent to Hetero Labs Ltd. Unit-V on 6/7/2017 by Genentech, Inc., OSI Pharmaceuticals, LLC. Waiver of Service due by 7/7/2017. (Fahnestock, Derek)
Jun 8, 2017 12 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by OSI Pharmaceuticals, LLC, Genentech, Inc.: For Hetero Labs Ltd. Unit-V waiver sent on 6/7/2017, answer due 8/7/2017. (Fahnestock, Derek)
Jun 7, 2017 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-00665-GMS, 1:17-cv-00666-GMS (rjb)
Jun 1, 2017 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Hetero Labs Ltd. on 6/1/2017; Hetero Labs Ltd. Unit-V on 6/1/2017; Hetero USA Inc. on 6/1/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs)
Jun 1, 2017 1 Complaint (8)
Jun 1, 2017 1 Exhibit A-B (48)
Jun 1, 2017 1 Civil Cover Sheet (1)
Jun 1, 2017 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs)
Jun 1, 2017 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/9/2017. Date of Expiration of Patent: 5/9/2021.Thirty Month Stay Deadline: 11/9/2019. (jcs)
Jun 1, 2017 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,900,221 B1. (jcs)
Jun 1, 2017 5 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US LLC, Corporate Parent Astellas US Holding, Inc. for OSI Pharmaceuticals, LLC filed by OSI Pharmaceuticals, LLC. (jcs)
Jun 1, 2017 6 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holding Ltd., Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc.. (jcs)
Jun 1, 2017 1 Main Document (8)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2153444.) - filed by OSI Pharmaceuticals, LLC, Genentech, Inc.. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(jcs)
Jun 1, 2017 1 Complaint* (1)
Menu